| UniProt ID | PPT1_HUMAN | |
|---|---|---|
| UniProt AC | P50897 | |
| Protein Name | Palmitoyl-protein thioesterase 1 | |
| Gene Name | PPT1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 306 | |
| Subcellular Localization | Lysosome . Secreted . | |
| Protein Description | Removes thioester-linked fatty acyl groups such as palmitate from modified cysteine residues in proteins or peptides during lysosomal degradation. Prefers acyl chain lengths of 14 to 18 carbons. [PubMed: 8816748] | |
| Protein Sequence | MASPGCLWLLAVALLPWTCASRALQHLDPPAPLPLVIWHGMGDSCCNPLSMGAIKKMVEKKIPGIYVLSLEIGKTLMEDVENSFFLNVNSQVTTVCQALAKDPKLQQGYNAMGFSQGGQFLRAVAQRCPSPPMINLISVGGQHQGVFGLPRCPGESSHICDFIRKTLNAGAYSKVVQERLVQAEYWHDPIKEDVYRNHSIFLADINQERGINESYKKNLMALKKFVMVKFLNDSIVDPVDSEWFGFYRSGQAKETIPLQETSLYTQDRLGLKEMDNAGQLVFLATEGDHLQLSEEWFYAHIIPFLG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | S-palmitoylation | --MASPGCLWLLAVA --CCCHHHHHHHHHH | 2.53 | 26731412 | |
| 18 | Phosphorylation | AVALLPWTCASRALQ HHHHHHHHHHHHHHH | 9.03 | 29083192 | |
| 21 | Phosphorylation | LLPWTCASRALQHLD HHHHHHHHHHHHCCC | 21.89 | 30631047 | |
| 62 | Ubiquitination | KKMVEKKIPGIYVLS HHHHHHCCCCEEEEE | 5.83 | 21963094 | |
| 66 | Phosphorylation | EKKIPGIYVLSLEIG HHCCCCEEEEEECCC | 10.97 | - | |
| 69 | Phosphorylation | IPGIYVLSLEIGKTL CCCEEEEEECCCCHH | 17.57 | - | |
| 71 | Ubiquitination | GIYVLSLEIGKTLME CEEEEEECCCCHHHH | 46.44 | 21890473 | |
| 71 | Ubiquitination | GIYVLSLEIGKTLME CEEEEEECCCCHHHH | 46.44 | 27667366 | |
| 75 | Phosphorylation | LSLEIGKTLMEDVEN EEECCCCHHHHHHHH | 26.56 | 24043423 | |
| 83 | Phosphorylation | LMEDVENSFFLNVNS HHHHHHHCEECCCHH | 12.13 | 24043423 | |
| 88 | Ubiquitination | ENSFFLNVNSQVTTV HHCEECCCHHHHHHH | 8.74 | 29967540 | |
| 90 | Phosphorylation | SFFLNVNSQVTTVCQ CEECCCHHHHHHHHH | 23.03 | 24043423 | |
| 93 | Phosphorylation | LNVNSQVTTVCQALA CCCHHHHHHHHHHHH | 13.08 | 24043423 | |
| 94 | Phosphorylation | NVNSQVTTVCQALAK CCHHHHHHHHHHHHC | 22.04 | 24043423 | |
| 113 | Ubiquitination | QQGYNAMGFSQGGQF HCCCCCCCCCHHHHH | 19.35 | 29967540 | |
| 150 | Ubiquitination | HQGVFGLPRCPGESS CCCCCCCCCCCCCHH | 35.89 | 21963094 | |
| 165 | Ubiquitination | HICDFIRKTLNAGAY HHHHHHHHHCCCCHH | 53.18 | 21963094 | |
| 172 | Phosphorylation | KTLNAGAYSKVVQER HHCCCCHHHHHHHHH | 14.22 | - | |
| 174 | Ubiquitination | LNAGAYSKVVQERLV CCCCHHHHHHHHHHH | 33.48 | 21906983 | |
| 174 | Ubiquitination | LNAGAYSKVVQERLV CCCCHHHHHHHHHHH | 33.48 | 21890473 | |
| 185 | Phosphorylation | ERLVQAEYWHDPIKE HHHHHHHHCCCCCCH | 15.85 | - | |
| 191 | Ubiquitination | EYWHDPIKEDVYRNH HHCCCCCCHHHHHCC | 53.93 | 29967540 | |
| 191 | Acetylation | EYWHDPIKEDVYRNH HHCCCCCCHHHHHCC | 53.93 | 26822725 | |
| 197 | N-linked_Glycosylation | IKEDVYRNHSIFLAD CCHHHHHCCCEEEHH | 18.64 | 16399764 | |
| 197 | N-linked_Glycosylation | IKEDVYRNHSIFLAD CCHHHHHCCCEEEHH | 18.64 | 16399764 | |
| 199 | O-linked_Glycosylation | EDVYRNHSIFLADIN HHHHHCCCEEEHHCC | 20.70 | 30059200 | |
| 212 | N-linked_Glycosylation | INQERGINESYKKNL CCHHCCCCHHHHHHH | 34.68 | 19159218 | |
| 216 | Ubiquitination | RGINESYKKNLMALK CCCCHHHHHHHHHHH | 44.45 | 29967540 | |
| 224 | Acetylation | KNLMALKKFVMVKFL HHHHHHHHHHHHHHC | 44.00 | 19811655 | |
| 224 | Ubiquitination | KNLMALKKFVMVKFL HHHHHHHHHHHHHHC | 44.00 | - | |
| 232 | N-linked_Glycosylation | FVMVKFLNDSIVDPV HHHHHHCCCCCCCCC | 44.08 | 12754519 | |
| 232 | N-linked_Glycosylation | FVMVKFLNDSIVDPV HHHHHHCCCCCCCCC | 44.08 | 12754519 | |
| 253 | Ubiquitination | FYRSGQAKETIPLQE EECCCCCCCEECCCC | 47.72 | 21963094 | |
| 261 | Phosphorylation | ETIPLQETSLYTQDR CEECCCCCCCCCCCC | 15.86 | 28152594 | |
| 262 | Phosphorylation | TIPLQETSLYTQDRL EECCCCCCCCCCCCC | 20.73 | 28152594 | |
| 264 | Phosphorylation | PLQETSLYTQDRLGL CCCCCCCCCCCCCCC | 11.34 | 28152594 | |
| 265 | Phosphorylation | LQETSLYTQDRLGLK CCCCCCCCCCCCCCE | 29.32 | 28152594 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PPT1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PPT1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PPT1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| XRCC1_HUMAN | XRCC1 | physical | 22939629 | |
| SPHM_HUMAN | SGSH | physical | 22939629 | |
| TMEM9_HUMAN | TMEM9 | physical | 22939629 | |
| RIF1_HUMAN | RIF1 | physical | 22939629 | |
| TCOF_HUMAN | TCOF1 | physical | 22939629 | |
| TERA_HUMAN | VCP | physical | 25865307 | |
| ODB2_HUMAN | DBT | physical | 25865307 | |
| MAP1B_HUMAN | MAP1B | physical | 25865307 | |
| VAPB_HUMAN | VAPB | physical | 25865307 | |
| AT1A1_HUMAN | ATP1A1 | physical | 25865307 | |
| PRDX1_HUMAN | PRDX1 | physical | 25865307 | |
| TXTP_HUMAN | SLC25A1 | physical | 25865307 | |
| ATPB_HUMAN | ATP5B | physical | 25865307 | |
| DPYL1_HUMAN | CRMP1 | physical | 25865307 | |
| ODP2_HUMAN | DLAT | physical | 25865307 | |
| CRIP2_HUMAN | CRIP2 | physical | 25865307 | |
| ATPA_HUMAN | ATP5A1 | physical | 25865307 | |
| DOPO_HUMAN | DBH | physical | 25865307 | |
| VGF_HUMAN | VGF | physical | 25865307 | |
| PRDX2_HUMAN | PRDX2 | physical | 25865307 | |
| ODPB_HUMAN | PDHB | physical | 25865307 | |
| PRDX5_HUMAN | PRDX5 | physical | 25865307 | |
| ODPA_HUMAN | PDHA1 | physical | 25865307 | |
| ATPO_HUMAN | ATP5O | physical | 25865307 | |
| CALX_HUMAN | CANX | physical | 25865307 | |
| CATD_HUMAN | CTSD | physical | 25865307 | |
| CMC2_HUMAN | SLC25A13 | physical | 25865307 | |
| VDAC2_HUMAN | VDAC2 | physical | 25865307 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 256730 | Ceroid lipofuscinosis, neuronal, 1 (CLN1) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-197; ASN-212 AND ASN-232,AND MASS SPECTROMETRY. | |
| "Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-232. | |